30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Buckbee Kevin K

Track

Insider profile

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Buckbee Kevin K's trades of Abbvie Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-28 2025-02-26
US Abbvie Inc (ABBV)
S Sale
26,407 -44.4%
430.83
US$2,846,511 		26,407 -44.4% 430.83 US$2,846,511
2025-02-28 2025-02-26
US Abbvie Inc (ABBV)
S Sale
86,174 -25.3%
496.20
US$3,936,350 		86,174 -25.3% 496.20 US$3,936,350
2025-02-26 2025-02-26
US Abbvie Inc (ABBV)
PrS Proposed sale
3,610
463.99
US$1,578,503 		3,610 463.99 US$1,578,503
2024-12-18 2024-12-16
US Abbvie Inc (ABBV)
S Sale
1,800 -20.5%
172.24
US$310,032 		1,800 -20.5% 172.24 US$310,032
2024-12-16 2024-12-16
US Abbvie Inc (ABBV)
PrS Proposed sale
1,800
172.25
US$310,045 		1,800 172.25 US$310,045
2024-03-01 2024-02-29
US Abbvie Inc (ABBV)
S Sale
5,144 -42.4%
176.65
US$908,688 		5,144 -42.4% 176.65 US$908,688
2024-02-29 2024-02-29
US Abbvie Inc (ABBV)
PrS Proposed sale
5,145
176.62
US$908,705 		5,145 176.62 US$908,705